Published 27 May 2009, doi:10.1136/bmj.b2064
Cite this as: BMJ 2009;338:b2064

Letters

Larval therapy for leg ulcers

Compression may be key

The first 100% of the full text of this article appears below.

Although larval therapy cleared leg ulcers in the study of Dumville and colleagues, it did not have any impact on the time to healing.1 In table 1 around 70% of patients in the hydrogel group received high compression—had a ankle brachial index >0.8—compared with around 50% in the larval groups. Compression is one of the cornerstones in treating chronic venous ulcers. Stronger compression in the larval group might have reduced the time to healing.

Cite this as: BMJ 2009;338:b2064

Anders Ternhag, specialist in infectious diseases1

1 Department of Infectious Diseases, Karolinska University Hospital, SE-171 76 Stockholm, Sweden

anders.ternhag@karolinska.se


Competing interests: None declared.

  1. Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, et al, on behalf of the VenUS II team. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009;338:b773. (19 March.)[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Larval therapy for leg ulcers (VenUS II): randomised controlled trial
Jo C Dumville, Gill Worthy, J Martin Bland, Nicky Cullum, Christopher Dowson, Cynthia Iglesias, Joanne L Mitchell, E Andrea Nelson, Marta O Soares, David J Torgerson on behalf of the VenUS II team
BMJ 2009 338: b773. [Abstract] [Full Text] [PDF]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ